Novartis Pharmaceuticals

SITE SELECTED: PINNACLE-MI: A randomized, double-blind, placebo-controlled, multi-center trial assessing the effect of pacibekitug on major cardiovascular events in participants after a myocardial infarction and at high cardiovascular risk